CD200 and acute myeloid leukemia: Since MDS-EB1, MDS-EB2, and AML-MRC are often accompanied by an increased number of bone marrow blasts [19], we examined whether expression levels of ALOX12 were correlated with the proportion of bone marrow blasts in patients with MDS.